Discovery of a Highly Potent and Selective BRD9 PROTAC Degrader Based on E3 Binder Investigation for the Treatment of Hematological Tumors

Haiting Duan(Zhejiang University), Jinxin Che(Pharmaceutical Biotechnology (Czechia)), Xiaojun Yao(Faculty (United Kingdom)), Hengyuan Yu(Zhejiang University), Ao Pang(Zhejiang University), Beijing Chen(Nanjing University of Information Science and Technology), Yubo Zhou(Sichuan Mianyang 404 Hospital), Jingyu Zhang(Hangzhou First People's Hospital), Yuwei Wang(Peking University), Yang Lu(Wuhan University), Nengming Lin(Hangzhou First People's Hospital), Tengfei Xu(China Agricultural University), Jia Li(Shanghai Institute of Materia Medica), Liteng Shen(Zhejiang Lab), Renzhao Gui(Zunyi Medical University), Bo Zhang(Hangzhou First People's Hospital), Xiaowu Dong(Second Affiliated Hospital of Zhejiang University)
Journal of Medicinal Chemistry
June 24, 2024
Cited by 19


Related Papers